Most Read Articles
04 Jun 2018
Digoxin therapy is more likely to reduce heart failure (HF) hospitalization in patients of the Digitalis Investigator Group (DIG) study who are at higher risk of hospitalization as identified by a multistate model, a posthoc analysis has shown.
Pearl Toh, 14 Nov 2020
Using vadadustat for treating anaemia in patients with chronic kidney disease (CKD) not on dialysis does not come with excess cardiovascular (CV) risk compared with darbepoetin alfa, particularly for those treated to a target Hb range of 10–11 g/dL, according to a prespecified analysis of the PRO2TECT study presented at ASN 2020 Kidney Week.
Pearl Toh, 06 Dec 2020
Adding ticagrelor to aspirin significantly reduces the risk of stroke and death compared with aspirin alone in patients with plaque build-up in their arteries known as ipsilateral atherosclerotic stenosis — thus highlighting the patient subgroup most likely to benefit from the combination therapy, based on a prespecified analysis of the THALES* study.
Audrey Abella, 18 Dec 2020
Omecamtiv mecarbil (OM), an investigational selective cardiac myosin activator, may reduce the risk of heart failure (HF)-related events or cardiovascular (CV) deaths in patients with chronic HFrEF*, according to the late-breaking GALACTIC-HF** trial presented at AHA 2020.

Product Highlight - Abokera

17 Dec 2020

Fight Hair Loss in 3 Steps.

  • Fortification Shampoo contains oleanolic acid, apigenin and biotin. These ingredients act together to nourish and repair the hair fiber. A frequent or daily use of the shampoo rebalances the physiological process, strengthens the weakened hair structure and gives density to the hair.
  • Fortification Intensive Lotion fights the ageing process and stimulates hair microcirculation, reinforcing the weakened structure. The active ingredients help to give body to the hair and stimulate the activity of the bulbs.
  • Fortification Intensive Lotion Plus makes hair stronger and thicker, giving them luster and a beautiful appearance. The product is enriched with 3% concentration of an effective and clinically tested formula resulting from the combined action of 3 active ingredients: Biotinyl-GHK (9 ppm), Apigenin and Oleanolic acid.

Reference:
https://www.vencare-italy.com/vencare-hair-care/#sezione_fortification_anti_loss

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Philippines digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
04 Jun 2018
Digoxin therapy is more likely to reduce heart failure (HF) hospitalization in patients of the Digitalis Investigator Group (DIG) study who are at higher risk of hospitalization as identified by a multistate model, a posthoc analysis has shown.
Pearl Toh, 14 Nov 2020
Using vadadustat for treating anaemia in patients with chronic kidney disease (CKD) not on dialysis does not come with excess cardiovascular (CV) risk compared with darbepoetin alfa, particularly for those treated to a target Hb range of 10–11 g/dL, according to a prespecified analysis of the PRO2TECT study presented at ASN 2020 Kidney Week.
Pearl Toh, 06 Dec 2020
Adding ticagrelor to aspirin significantly reduces the risk of stroke and death compared with aspirin alone in patients with plaque build-up in their arteries known as ipsilateral atherosclerotic stenosis — thus highlighting the patient subgroup most likely to benefit from the combination therapy, based on a prespecified analysis of the THALES* study.
Audrey Abella, 18 Dec 2020
Omecamtiv mecarbil (OM), an investigational selective cardiac myosin activator, may reduce the risk of heart failure (HF)-related events or cardiovascular (CV) deaths in patients with chronic HFrEF*, according to the late-breaking GALACTIC-HF** trial presented at AHA 2020.